Stereotactic Ablative Radiotherapy for Lung Cancer

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Stereotactic ablative radiotherapy (SABR), historically known as stereotactic body radiation therapy (SBRT), has rapidly developed into an important tool radiation oncologists use in the treatment of lung cancers. The indications for treatment of medically inoperable lung cancers have become well established. SABR is also being evaluated more frequently in the setting of operable lung cancers, metastases from primary tumors to the lungs and other anatomic sites, and oligometastatic lung disease as well. This chapter highlights the biologic, technologic, and clinical advances that have led to the increased acceptance and use of SABR in mainstream radiation oncology practices for lung cancer.

Original languageEnglish (US)
Title of host publicationLung Cancer: Fourth Edition
PublisherWiley Blackwell
Pages320-337
Number of pages18
Volume9781118468746
ISBN (Print)9781118468791, 9781118468746
DOIs
StatePublished - May 27 2014

Fingerprint

Lung Neoplasms
Radiotherapy
Radiation Oncology
Lung Diseases
Neoplasm Metastasis
Lung
Therapeutics
Neoplasms

Keywords

  • Lung cancer
  • SBRT
  • Stereotactic ablative radiotherapy
  • Stereotactic body radiation therapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Iyengar, P., & Timmerman, R. D. (2014). Stereotactic Ablative Radiotherapy for Lung Cancer. In Lung Cancer: Fourth Edition (Vol. 9781118468746, pp. 320-337). Wiley Blackwell. https://doi.org/10.1002/9781118468791.ch21

Stereotactic Ablative Radiotherapy for Lung Cancer. / Iyengar, Puneeth; Timmerman, Robert D.

Lung Cancer: Fourth Edition. Vol. 9781118468746 Wiley Blackwell, 2014. p. 320-337.

Research output: Chapter in Book/Report/Conference proceedingChapter

Iyengar, P & Timmerman, RD 2014, Stereotactic Ablative Radiotherapy for Lung Cancer. in Lung Cancer: Fourth Edition. vol. 9781118468746, Wiley Blackwell, pp. 320-337. https://doi.org/10.1002/9781118468791.ch21
Iyengar P, Timmerman RD. Stereotactic Ablative Radiotherapy for Lung Cancer. In Lung Cancer: Fourth Edition. Vol. 9781118468746. Wiley Blackwell. 2014. p. 320-337 https://doi.org/10.1002/9781118468791.ch21
Iyengar, Puneeth ; Timmerman, Robert D. / Stereotactic Ablative Radiotherapy for Lung Cancer. Lung Cancer: Fourth Edition. Vol. 9781118468746 Wiley Blackwell, 2014. pp. 320-337
@inbook{15ed4fd252094af893b7586ed83d0c65,
title = "Stereotactic Ablative Radiotherapy for Lung Cancer",
abstract = "Stereotactic ablative radiotherapy (SABR), historically known as stereotactic body radiation therapy (SBRT), has rapidly developed into an important tool radiation oncologists use in the treatment of lung cancers. The indications for treatment of medically inoperable lung cancers have become well established. SABR is also being evaluated more frequently in the setting of operable lung cancers, metastases from primary tumors to the lungs and other anatomic sites, and oligometastatic lung disease as well. This chapter highlights the biologic, technologic, and clinical advances that have led to the increased acceptance and use of SABR in mainstream radiation oncology practices for lung cancer.",
keywords = "Lung cancer, SBRT, Stereotactic ablative radiotherapy, Stereotactic body radiation therapy",
author = "Puneeth Iyengar and Timmerman, {Robert D.}",
year = "2014",
month = "5",
day = "27",
doi = "10.1002/9781118468791.ch21",
language = "English (US)",
isbn = "9781118468791",
volume = "9781118468746",
pages = "320--337",
booktitle = "Lung Cancer: Fourth Edition",
publisher = "Wiley Blackwell",

}

TY - CHAP

T1 - Stereotactic Ablative Radiotherapy for Lung Cancer

AU - Iyengar, Puneeth

AU - Timmerman, Robert D.

PY - 2014/5/27

Y1 - 2014/5/27

N2 - Stereotactic ablative radiotherapy (SABR), historically known as stereotactic body radiation therapy (SBRT), has rapidly developed into an important tool radiation oncologists use in the treatment of lung cancers. The indications for treatment of medically inoperable lung cancers have become well established. SABR is also being evaluated more frequently in the setting of operable lung cancers, metastases from primary tumors to the lungs and other anatomic sites, and oligometastatic lung disease as well. This chapter highlights the biologic, technologic, and clinical advances that have led to the increased acceptance and use of SABR in mainstream radiation oncology practices for lung cancer.

AB - Stereotactic ablative radiotherapy (SABR), historically known as stereotactic body radiation therapy (SBRT), has rapidly developed into an important tool radiation oncologists use in the treatment of lung cancers. The indications for treatment of medically inoperable lung cancers have become well established. SABR is also being evaluated more frequently in the setting of operable lung cancers, metastases from primary tumors to the lungs and other anatomic sites, and oligometastatic lung disease as well. This chapter highlights the biologic, technologic, and clinical advances that have led to the increased acceptance and use of SABR in mainstream radiation oncology practices for lung cancer.

KW - Lung cancer

KW - SBRT

KW - Stereotactic ablative radiotherapy

KW - Stereotactic body radiation therapy

UR - http://www.scopus.com/inward/record.url?scp=84927144886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927144886&partnerID=8YFLogxK

U2 - 10.1002/9781118468791.ch21

DO - 10.1002/9781118468791.ch21

M3 - Chapter

SN - 9781118468791

SN - 9781118468746

VL - 9781118468746

SP - 320

EP - 337

BT - Lung Cancer: Fourth Edition

PB - Wiley Blackwell

ER -